(Sharecast News) - Oncimmune Holdings, an autoantibody profiling specialist, announced a major recapitalisation to fuel its next growth phase on Friday.
The AIM-traded firm said the move included a fundraising effort and the conversion of around €4m of existing debt into equity.

It came as the company continued to gain...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE